Bristol-Myers Squibb: Colitis, Ulcerative trials

The registry lists 22 Colitis, Ulcerative studies with Bristol-Myers Squibb as lead sponsor. 4 are open to participants now and 9 have results posted.

Phase 1 3Phase 2 8Phase 3 6Phase 4 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative ColitisRecruitingNCT07271069
• A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in KoreaRecruitingNCT06073873
• A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their OffspringRecruitingNCT05953402
• A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative ColitisRecruitingNCT05076175Phase 2/3
• An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical PracticeTerminatedNCT05369832Phase 4Results posted
• A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative ColitisCompletedNCT04877990Phase 2Results posted
• A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative ColitisCompletedNCT04613518Phase 2Results posted
• Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative ColitisCompletedNCT03934216Phase 2Results posted
• An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative ColitisCompletedNCT02601300Phase 2Results posted
• An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative ColitisCompletedNCT02531126Phase 3Results posted
• Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative ColitisCompletedNCT02435992Phase 3Results posted
• Efficacy and Safety Study of Ozanimod in Ulcerative ColitisCompletedNCT01647516Phase 2Results posted
• A Study of Abatacept in Patients With Active Ulcerative ColitisCompletedNCT00410410Phase 3Results posted
• A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their InfantsActive, not recruitingNCT06126835
• A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)TerminatedNCT05644665Phase 3
• A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative ColitisTerminatedNCT05382715
• To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative ColitisCompletedNCT03915769Phase 3
• A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy VolunteersCompletedNCT03038711Phase 1
• Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative ColitisTerminatedNCT02864264Phase 1
• Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative ColitisCompletedNCT01294410Phase 2
• A Study of MDX-1100 in Subjects With Active Ulcerative ColitisCompletedNCT00656890Phase 2
• A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative ColitisCompletedNCT00295282Phase 1